Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Expert Practical Recommendations for Hepatocellular Carcinoma103
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns40
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma37
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD33
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype27
Genetic and Epigenetic Basis of Drug-Induced Liver Injury26
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease26
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease25
HBV Biomarkers and Their Role in Guiding Treatment Decisions24
Towards Precision Medicine in MASLD: Evolution of Disease Subtyping23
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis23
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy20
MASH-Associated T Cell Activation and Neuroinflammation: Evidence for a Hepatosystemic Immune Axis20
Physiomimetic In Vitro Human Models for Viral Infection in the Liver19
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury19
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies17
0.10283613204956